South Korea debates covering hair-loss treatment under public insurance
A government proposal to pay for common hair-loss treatments has angered doctors and patient groups, who say the money should go to people with serious illnesses.
South Korea's government is thinking about using public health insurance money to pay for hair-loss treatments. This idea has caused a lot of pushback from doctors and patient groups across the country. They say the money should be saved for people who are seriously ill. The debate is happening in Seoul, and a public forum is planned for July 4, 2026.
South Korea has a national health insurance system that is meant to cover treatments people truly need for their health. The government is now asking whether common male-pattern hair loss — the kind caused by aging and genetics — should count as a medical need. Health and Welfare Minister Jung Eun-kyeong named this as one of the government's top goals for the second half of 2026. The government is thinking about starting with younger adults who are just entering the job market.
The idea got more attention after politician Lee Jae Myung said in 2025 that hair loss is 'a matter of survival.' He argued that losing hair can hurt a person's social life and job chances. Some people agree that the emotional effects of hair loss are real and serious. But many medical experts say those reasons are not strong enough to justify using public funds.
Critics say public health insurance should focus on life-threatening conditions, not appearance-related ones. Professor Chung Jae-hoon from Korea University wrote on social media that hair loss caused by aging and genes 'is not a disease that threatens life or bodily function.' He warned that if hair loss is covered, people will start asking why other things — like poor eyesight, wrinkles, or age spots — are not covered too. He also pointed out that some adult vaccines and obesity medicines, which have strong medical evidence behind them, still aren't covered by insurance.
Chung estimated that covering hair-loss medicines could cost between 100 billion won (about $84 million) and 700 billion won each year. The exact cost would depend on how many people use the benefit and what treatments are included. That is a huge range, and it shows how uncertain the plan still is. Many experts worry the real cost could end up being much higher than expected.
Professor Kim Hyun-cheol from Yonsei University also spoke out against the plan. He said most health policy experts would oppose it because it goes against the main purpose of national insurance. He pointed out that many patients with rare or severe diseases already struggle to pay for treatments that aren't covered. Spending money on hair loss, he argued, makes that problem worse.
Patient groups joined the criticism, too. The Korea Alliance of Patients Organisation called the proposal 'a dangerous populist policy.' They said it could damage the rules that guide how the insurance system spends its money. Their statement said it is hard to justify spending on a condition that does not threaten life while serious disease treatments are already delayed because of tight budgets.
South Korea's health insurance system almost never pays for cosmetic, or appearance-related, treatments. Right now, it only covers certain medical types of hair loss, like a condition called alopecia areata. Common male-pattern hair loss is not included. Critics are worried that changing this rule could open the door for many other appearance-related conditions to demand coverage as well.
There are also bigger worries about the long-term health of the insurance system itself. The government says the system's reserve funds — which reached a record 30.2 trillion won in 2025 — could run out by 2033. This is because South Korea's population is getting older, and healthcare costs keep rising. Adding new coverage areas like hair loss could speed up that problem.
The Health Ministry plans to hold a public forum on July 4 to gather more opinions. After that, any final decision would need to be approved by the Health Insurance Policy Deliberation Committee. Until that committee votes, no change to coverage can happen. For now, the debate is far from over.
There are still patients with rare diseases and severe illnesses who face enormous financial burdens because innovative treatments remain outside insurance coverage or are subject to strict reimbursement standards.
Comprehension quiz preview
1. Who is South Korea's Health and Welfare Minister mentioned in the article?
2. According to Professor Chung, how much could covering hair-loss medicines cost per year at the high end?
3. By what year does the government project the insurance system's reserve funds could run out?